~~<i id='E6435FC925'><strike id='E6435FC925'><tt id='E6435FC925'><pre id='E6435FC925'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：hotspot 2025-10-02 08:26:23 Page View：77

On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Is mRNA technology the right fit for flu shots? Experts aren’t so sure
Next article： Peter Hotez and the public health issue of online harassment

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Pharma companies must ensure equitable access to obesity drugs

TheobesitydrugWegovyisseenatapharmacyinChicago.ScottOlson/GettyImagesWeightlosstreatmentshavethepote

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

How faith leaders like me can help address America's obesity epidemic

AdobeManyfactorsdriveAmerica’sobesityepidemic—environment,genetics,eatinghabits,andmore.Solvingthepr